Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53.
Skin Irritancy Tests
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53.
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53. Int J Cancer. 2020 08 15; 147(4):1086-1097.
View in:
PubMed
subject areas
Animals
Apoptosis
Aza Compounds
Bridged Bicyclo Compounds, Heterocyclic
Cell Line, Tumor
Chromans
Female
HSP70 Heat-Shock Proteins
Humans
Maintenance Chemotherapy
Mice, Nude
Molecular Targeted Therapy
Mutation
Ovarian Neoplasms
Thiones
Tumor Suppressor Protein p53
Xenograft Model Antitumor Assays
authors with profiles
Yan Daniel Zhao
Doris M Benbrook
Zitha Redempta Isingizwe